Interestingly, one adipokine (LCN2) and two chemokines (CXCL1, CXCL9) were included in the top 14 genes identified as candidate NASH markers (Table 2). The gene discussed is CXCL9; the disease is metabolic dysfunction-associated steatohepatitis.